Date: 2012-04-06
Type of information:
Product name: heterologous human adult liver-derived stem cells
Compound: heterologous human adult liver-derived stem cells
Therapeutic area:
Action mechanism:
Company: Fresenius Medical Care (Germany)
Disease: carbamoyl-phosphate synthase-1 deficiency
Latest news:
Patents:
Submission of marketing authorization application USA :
Submission of marketing authorization application UE:
Withdrawal of marketing authorization application USA:
Withdrawal of marketing authorization application UE:
US authorization:
UE authorization:
Favourable opinion UE:
Favourable opinion USA:
Orphan status USA:
Orphan status UE: 2012-03-05
Pediatric exclusivit _USA:
Pediatric exclusivity UE: OTC status: Other news:
